Clinical Investigation of Two Different Wound Dressings
NCT ID: NCT02904200
Last Updated: 2021-04-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
2 participants
INTERVENTIONAL
2016-10-31
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary objectives are to evaluate pain before, during, and after dressing removal from baseline to termination
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Confirm the Safety and Performance of Avance Solo NPWT System
NCT04754048
Wound Dressing With Moisture Sensor
NCT03468816
Confirm Safety and Performance of Avance Solo and Avance Solo Adapt NPWT Systems
NCT04753294
Post Market Clinical Follow Up Study of Avance Foam Abdominal Dressing Kit in Open Abdomen
NCT01968811
A Study Comparing V.A.C. Negative Pressure Wound Therapy (NPWT) to Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Amputation Wounds
NCT00837096
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Male or female, 18 years or older with following wound types:
* traumatic, surgical or dehisced wounds,
* venous leg ulcer or pressure ulcer will be included into the clinical investigation.
32 evaluated subjects (i:e 16 subjects per arm) will be followed during maximum three weeks. The treatment arm (either silicon adhesive dressing or acrylic adhesive dressing). Patients will be randomized using optimal allocation (minimization) balancing for the following baseline variables type of skin (normal/dry/flaky/oily/moist) and age. Eligible patients will be randomized to receive either silicon adhesive dressing or acrylic adhesive dressing in a ratio of 1:1 provided.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Silicon adhesive dressing
Sterile soft silicon adhesive dressing
Silicon adhesive dressing
Sterile soft silicon adhesive dressing
Acrylic adhesive dressing
Sterile acrylic adhesive dressing
Acrylic adhesive dressing
Sterile acrylic adhesive dressing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Silicon adhesive dressing
Sterile soft silicon adhesive dressing
Acrylic adhesive dressing
Sterile acrylic adhesive dressing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. In case of multiple wounds the target wound must be ≥10 cm distant from other wounds. Selection of the target wound is according to the investigator's preference.
3. Peri-wound skin assessable and 5 cm of peri-wound skin present around the wound
4. Male or female, 18 years of age and above
5. Signed Informed Consent
Exclusion Criteria
2. Unexplored blind tunnels or non-enteric fistula
3. Untreated osteomyelitis
4. Malignant wounds
5. Subjects treated with systemic immunosuppressive or glucocorticosteroids, except subjects taking occasional doses or doses less than 10mg prednisolon/day or equivalent.
6. Wounds with necrotic tissue or eschar (if not adequately debrided)
7. Significantly bleeding wounds, as judged by the investigator
8. Subject not suitable for the investigation according to the investigator's judgment
9. Subject included in other ongoing clinical investigation which could interfere with this investigation, as judged by the investigator
10. Known allergy/hypersensitivity to any of the components included into the investigation.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Molnlycke Health Care AB
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marianne Bergstrom
Role: PRINCIPAL_INVESTIGATOR
Sundsvalls Sjukhus
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sundsvalls sjukhus
Sundsvall, , Sweden
Norrlands Universitetssjukhus
Umeå, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Avance 02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.